20.01.2010 06:00:00
|
ASML Announces 2009 Fourth Quarter and Full Year Results
ASML Holding NV (ASML) today announces 2009 fourth quarter and full year results according to US GAAP as follows:
- Q4 2009 net sales of EUR 581 million versus Q3 2009 net sales of EUR 555 million (Q4 2008 net sales of EUR 494 million). Full year 2009 net sales were EUR 1,596 million, down 46.0 percent versus 2008 net sales of EUR 2,954 million.
- Q4 2009 net income of EUR 50 million, or 8.7 percent of net sales, versus Q3 2009 net income of EUR 20 million, or 3.6 percent of net sales (Q4 2008 net loss of EUR 88 million or 17.8 percent of net sales). Full year 2009 net loss amounted to EUR 151 million or 9.5 percent of net sales, compared with 2008 net income of EUR 322 million or 10.9 percent of net sales.
- Q4 2009 net bookings valued at EUR 956 million with 40 systems including 35 new and 5 used systems, leading to an order backlog valued at EUR 1,853 million as of December 31, 2009.
"We closed the year as planned with improved sales and strong bookings, as the semiconductor business recovers, driven by technology buys from the memory market segments and technology and capacity buys from major Foundry customers,” said Eric Meurice, president and Chief Executive Officer of ASML. "Thanks to our continued heavy investments in Research & Development we have been able to ramp up our new mid-range and top-of-the-range platforms, respectively the XT:1950Hi and the NXT:1950i scanners. In parallel, we are making good progress with our next generation EUV technology, as system integration and source performance development confirms shipments of the first pre-production systems in the second half of 2010. We thus closed off a challenging year, having generated cash from operations, set up a more efficient cost structure and built an even stronger product portfolio,” Meurice said.
Operations Update
Full year 2009 net sales of EUR 1,596 million consisted of system sales of EUR 1,175 million, as the company shipped a total of 70 systems, including 47 new and 23 used, and net service and field option sales which amounted to EUR 421 million. 2008 net sales of EUR 2,954 million consisted of net system sales of EUR 2,517 million, as the company shipped a total of 151 systems, including 115 new and 36 used, and net service and field option sales of EUR 437 million.
In Q4 2009, ASML’s net sales of EUR 581 million included 19 new and 6 used systems, totaling net system sales of EUR 432 million, and net service and field option sales of EUR 149 million. Net system sales for Q3 2009 included the shipment of 17 new and 7 used machines, totaling EUR 459 million, and net service and field option sales of EUR 96 million.
The Q4 2009 average selling price for a new system was EUR 19.7 million, reflecting a mix of immersion scanners aimed at technology upgrades and a number of complementary dry systems for less critical layers, compared with the Q3 2009 average selling price for a new system of EUR 23.4 million. The Q4 2009 average selling price for all ASML systems sold was EUR 17.3 million, compared with the Q3 2009 average selling price for all ASML systems sold of EUR 19.1 million.
Q4 2009 net bookings totaled 40 systems valued at EUR 956 million.
ASML’s order backlog as of December 31, 2009 was EUR 1,853 million, totaling 69 systems with an average selling price of EUR 26.8 million. ASML’s backlog as of September 27, 2009 was valued at EUR 1,353 million, totaling 54 systems with an average selling price of EUR 25.1 million.
In Q4 2009, ASML generated a net income of EUR 50 million, or EUR 0.12 net income per ordinary share as compared with a net income in Q3 2009 of EUR 20 million or EUR 0.05 net income per ordinary share. We recorded a net loss of EUR 151 million (EUR 0.35 net loss per ordinary share) for the 2009 full year, compared with a net income of EUR 322 million (EUR 0.75 net income per ordinary share) for 2008.
The company’s Q4 2009 gross margin was 38.0 percent. This margin is the result of an improvement of the company’s cost structure and stronger service and field option sales and compares with the Q3 2009 gross margin of 34.4 percent.
Q4 2009 research and development (R&D) costs were EUR 115 million including credits versus Q3 2009 R&D costs of EUR 115 million including credits.
Selling, general and administrative (SG&A) costs were EUR 37 million in Q4 2009, compared with SG&A costs of EUR 38 million in Q3 2009.
Net cash generated was EUR 19 million in Q4 2009. ASML ended Q4 2009 with EUR 1,037 million in cash and cash equivalents, compared with EUR 1,018 million by the end of Q3 2009.
Outlook
"We booked EUR 956 million of systems in the fourth quarter of 2009 and expect bookings of the same order of magnitude for the first quarter of 2010, confirming an upturn of the semiconductor industry,” Eric Meurice said. "Of our backlog, 49 units are for new immersion systems, including 17 advanced NXT:1950i scanners. The immersion bookings continue to be led by technology upgrades required to manufacture our customers’ richer mix of new semiconductor designs: mainly 40 nanometer (nm) DRAM memory chips and Logic integrated circuits, but also 20s and 30s nm NAND Flash memory products. Shipments will continue to grow, with the first quarter somewhat restricted, due to standard - long - equipment industry production lead times and new product introduction challenges, followed by a much higher second quarter,” Meurice added.
ASML expects net sales of around EUR 700 million in Q1 2010 and of around EUR 950 million in Q2 2010. We expect gross margin in Q1 2010 of about 40 percent. R&D expenditures are expected to be at EUR 120 million and SG&A costs are expected at EUR 40 million.
ASML will submit a proposal to the 2010 General Meeting of Shareholders to declare an unchanged dividend paid in respect of 2009 of EUR 0.20 per ordinary share (approximately EUR 87 million) (EUR 0.20 per ordinary share paid in respect of 2008).
About ASML
ASML is the world's leading provider of lithography systems for the semiconductor industry, manufacturing complex machines that are critical to the production of integrated circuits or chips. Headquartered in Veldhoven, the Netherlands, ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. ASML has more than 6,500 employees (expressed in full time equivalents), serving chip manufacturers in more than 60 locations in 15 countries. More information about our company, our products and technology, and career opportunities is available on our website: www.asml.com
2009 Annual Report on Form 20-F
ASML will publish its 2009 Annual Report on Form 20-F on February 2, 2010 at the latest. The report will be published on our website at www.asml.com.
Press Conference
A press conference hosted by CEO Eric Meurice and CFO Peter Wennink will be held at 11:00 AM Central European Time / 05:00 AM Eastern U.S. time. To listen to the press conference, access is available via www.asml.com
A presentation about 2009 fourth quarter and full year results is available on www.asml.com
A video statement of CFO Peter Wennink is available on www.asml.com
Investor and Media Conference Call
A conference call for investors and media will be hosted by CEO Eric Meurice and CFO Peter Wennink at 15:00 PM Central European Time / 09:00 AM Eastern U.S. time. Dial-in numbers are: in the Netherlands +31 10 29 44 271 and the US +1 706 679 04 73. To listen to the conference call, access is also available via www.asml.com
A replay of the Investor and Media Call will be available on www.asml.com
IFRS Financial Reporting
ASML's primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting principles generally accepted in the United States. Quarterly US GAAP consolidated statements of operations, consolidated statements of cash flows, consolidated balance sheets, and a reconciliation of net income/(loss) and equity from US GAAP to IFRS as adopted by the European Union (IFRS) are available on www.asml.com
In addition to reporting financial figures in accordance with US GAAP, ASML also reports financial figures in accordance with IFRS for statutory purposes. The most significant differences between US GAAP and IFRS that affect ASML concern the capitalization of certain product development costs, the accounting of share-based payment plans, the accounting of income taxes and the accounting of reversal of inventory write-downs. Quarterly IFRS consolidated income statements, consolidated statements of cash flows, consolidated statements of financial position and a reconciliation of net income/(loss) and equity from US GAAP to IFRS are available on www.asml.com
The consolidated balance sheets of ASML Holding N.V. as of December 31, 2009, the related consolidated statements of operations and consolidated statements of cash flows for the quarter ended December 31, 2009 as presented in this press release are unaudited.
Regulated Information
This press release, the US GAAP consolidated financial statements and the IFRS consolidated financial statements published on www.asml.com comprise regulated information within the meaning of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht).
Forward Looking Statements
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers’ products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.
ASML - Summary U.S. GAAP Consolidated Statements of Operations 1 |
|||||||||||
Three months ended, | Twelve months ended, | ||||||||||
Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2009 | ||||||||
(in thousands EUR, except per share data) | |||||||||||
Net system sales | 380,466 | 431,808 | 2,516,762 | 1,174,858 | |||||||
Net service and field option sales | 113,354 | 148,758 | 436,916 | 421,205 | |||||||
Total net sales | 493,820 | 580,566 | 2,953,678 | 1,596,063 | |||||||
Cost of sales | 454,830 | 360,233 | 1,938,164 | 1,137,671 | |||||||
Gross profit on sales | 38,990 | 220,333 | 1,015,514 | 458,392 | |||||||
Research and development costs | 127,471 | 115,390 | 516,128 | 466,761 | |||||||
Selling, general and administrative costs | 46,712 | 37,134 | 212,341 | 156,644 | |||||||
Income (loss) from operations | (135,193 | ) | 67,809 | 287,045 | (165,013 | ) | |||||
Interest income (expense) | 4,965 | (2,885 | ) | 22,599 | (6,537 | ) | |||||
Income (loss) from operations before income taxes | (130,228 | ) | 64,924 | 309,644 | (171,550 | ) | |||||
(Provision for) benefit from income taxes | 42,204 | (14,444 | ) | 12,726 | 20,625 | ||||||
Net income (loss) | (88,024 | ) | 50,480 | 322,370 | (150,925 | ) | |||||
Basic net income (loss) per ordinary share | (0.20 | ) | 0.12 | 0.75 | (0.35 | ) | |||||
Diluted net income (loss) per ordinary share(2) | (0.20 | ) | 0.12 | 0.74 | (0.35 | ) | |||||
Number of ordinary shares used in computing per share amounts (in thousands): | |||||||||||
Basic | 431,989 | 433,230 | 431,620 | 432,615 | |||||||
Diluted(2) | 431,989 | 436,953 | 434,205 | 432,615 | |||||||
ASML - Ratios and Other Data 1 | |||||||||||
Three months ended, | Twelve months ended, | ||||||||||
Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2009 | ||||||||
Gross profit as a % of net sales | 7.9 | 38.0 | 34.4 | 28.7 | |||||||
Income (loss) from operations as a % of net sales | (27.4 | ) | 11.7 | 9.7 | (10.3 | ) | |||||
Net income (loss) as a % of net sales | (17.8 | ) | 8.7 | 10.9 | (9.5 | ) | |||||
Shareholders’ equity as a % of total assets | 50.5 | 47.6 | 50.5 | 47.6 | |||||||
Income taxes as a % of income before income taxes | (32.4 | ) | (22.2 | ) | 4.1 | (12.0 | ) | ||||
Sales of systems (in units) | 25 | 25 | 151 | 70 | |||||||
ASP of systems sales (EUR million) | 15.2 | 17.3 | 16.7 | 16.8 | |||||||
Value of systems backlog (EUR million) | 755 | 1,853 | 755 | 1,853 | |||||||
Systems backlog (in units) | 41 | 69 | 41 | 69 | |||||||
ASP of systems backlog (EUR million) | 18.4 | 26.8 | 18.4 | 26.8 | |||||||
Value of booked systems (EUR million) | 127 | 956 | 1,569 | 2,334 | |||||||
Net bookings (in units) | 13 | 40 | 103 | 98 | |||||||
ASP of booked systems (EUR million) | 9.8 | 23.9 | 15.2 | 23.8 | |||||||
Number of payroll employees in FTEs | 6,930 | 6,548 | 6,930 | 6,548 | |||||||
Number of temporary employees in FTEs | 1,329 | 1,137 | 1,329 | 1,137 | |||||||
ASML - Summary U.S. GAAP Consolidated Balance Sheets 1 | ||||
Dec 31, 2008 | Dec 31, 2009 | |||
(in thousands EUR) | ||||
ASSETS | ||||
Cash and cash equivalents | 1,109,184 | 1,037,074 | ||
Accounts receivable, net | 463,273 | 377,439 | ||
Finance receivables, net | 6,225 | 21,553 | ||
Current tax assets | 87,560 | 11,286 | ||
Inventories, net | 999,150 | 963,382 | ||
Deferred tax assets | 71,780 | 119,404 | ||
Other assets | 236,077 | 218,746 | ||
Total current assets | 2,973,249 | 2,748,884 | ||
Finance receivables, net | 31,030 | - | ||
Deferred tax assets | 148,133 | 133,263 | ||
Other assets | 88,197 | 77,054 | ||
Goodwill | 131,453 | 131,462 | ||
Other intangible assets, net | 26,692 | 18,128 | ||
Property, plant and equipment, net | 540,640 | 618,706 | ||
Total non-current assets | 966,145 | 978,613 | ||
Total assets | 3,939,394 | 3,727,497 | ||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||
Current liabilities | 1,008,343 | 1,044,170 | ||
Accrued liabilities and other liabilities | 70,038 | 44,359 | ||
Deferred and other tax liabilities | 209,699 | 188,404 | ||
Provisions | 15,495 | 12,694 | ||
Long-term debt | 647,050 | 663,102 | ||
Total non-current liabilities | 942,282 | 908,559 | ||
Total liabilities | 1,950,625 | 1,952,729 | ||
Shareholders’ equity | 1,988,769 | 1,774,768 | ||
Total liabilities and shareholders’ equity | 3,939,394 | 3,727,497 | ||
ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1 | ||||||||||||
Three months ended, | Twelve months ended, | |||||||||||
Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2009 | |||||||||
(in thousands EUR) | ||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||
Net income (loss) | (88,024 | ) | 50,480 | 322,370 | (150,925 | ) | ||||||
Depreciation and amortization | 35,088 | 33,638 | 119,190 | 140,201 | ||||||||
Impairment | 22,913 | 326 | 25,109 | 15,896 | ||||||||
Loss on disposals of property, plant and equipment | 430 | 1,016 | 4,257 | 4,053 | ||||||||
Share-based payments | 3,173 | 4,515 | 13,535 | 13,394 | ||||||||
Allowance for doubtful debts | 501 | 53 | 188 | 1,889 | ||||||||
Allowance for obsolete inventory | 85,777 | 7,410 | 139,628 | 86,636 | ||||||||
Deferred income taxes | (2,708 | ) | 13,272 | (34,155 | ) | (49,423 | ) | |||||
Change in assets and liabilities | (194,586 | ) | (91,661 | ) | (309,376 | ) | 36,043 | |||||
Net cash provided by (used in) operating activities | (137,436 | ) | 19,049 | 280,746 | 97,764 | |||||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||||
Purchases of property, plant and equipment | (71,060 | ) | (7,692 | ) | (259,770 | ) | (104,959 | ) | ||||
Proceeds from sale of property, plant and equipment | - | - | - | 6,877 | ||||||||
Purchases of intangible assets | - | - | (35 | ) | - | |||||||
Net cash used in investing activities | (71,060 | ) | (7,692 | ) | (259,805 | ) | (98,082 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||
Dividend paid | - | - | (107,841 | ) | (86,486 | ) | ||||||
Purchase of shares in conjunction with | ||||||||||||
share-based payment plans | - | - | (87,605 | ) | - | |||||||
Net proceeds from issuance of shares and stock options | 6,509 | 6,359 | 11,475 | 11,073 | ||||||||
Excess tax benefits (deficiencies) from stock options | (1,883 | ) | 991 | 2,144 | 1,954 | |||||||
Net proceeds from other long-term debt | - | - | - | 32 | ||||||||
Redemption and/or repayment of debt | (1,131 | ) | (4 | ) | (2,411 | ) | (17 | ) | ||||
Net cash provided by (used in) financing activities | 3,495 | 7,346 | (184,238 | ) | (73,444 | ) | ||||||
Net cash flows | (205,001 | ) | 18,703 | (163,297 | ) | (73,762 | ) | |||||
Effect of changes in exchange rates on cash | 1,192 | 343 | 845 | 1,652 | ||||||||
Net increase (decrease) in cash & cash equivalents | (203,809 | ) | 19,046 | (162,452 | ) | (72,110 | ) | |||||
ASML - Quarterly Summary U.S. GAAP Consolidated Statements of Operations 1 |
|||||||||||||||
|
|||||||||||||||
Three months ended, | |||||||||||||||
Dec 31, | Mar 29, | Jun 28, | Sep 27, | Dec 31, | |||||||||||
2008 | 2009 | 2009 | 2009 | 2009 | |||||||||||
(in millions EUR, except per share data) | |||||||||||||||
Net system sales | 380.5 | 101.1 | 183.3 | 458.7 | 431.8 | ||||||||||
Net service and field option sales | 113.3 | 82.5 | 93.3 | 96.6 | 148.8 | ||||||||||
Total net sales | 493.8 | 183.6 | 276.6 | 555.3 | 580.6 | ||||||||||
Cost of sales | 454.8 | 171.2 | 242.2 | 364.0 | 360.3 | ||||||||||
Gross profit on sales | 39.0 | 12.4 | 34.4 | 191.3 | 220.3 | ||||||||||
Research and development costs | 127.5 | 118.3 | 117.9 | 115.2 | 115.4 | ||||||||||
Selling, general and administrative costs | 46.7 | 41.0 | 41.0 | 37.5 | 37.1 | ||||||||||
Income (loss) from operations | (135.2 | ) | (146.9 | ) | (124.5 | ) | 38.6 | 67.8 | |||||||
Interest income (expense) | 5.0 | (1.1 | ) | (0.2 | ) | (2.4 | ) | (2.9 | ) | ||||||
Income (loss) from operations before income taxes | (130.2 | ) | (148.0 | ) | (124.7 | ) | 36.2 | 64.9 | |||||||
(Provision for) benefit from income taxes | 42.2 | 30.8 | 20.7 | (16.5 | ) | (14.4 | ) | ||||||||
Net income (loss) | (88.0 | ) | (117.2 | ) | (104.0 | ) | 19.7 | 50.5 | |||||||
Basic net income (loss) per ordinary share | (0.20 | ) | (0.27 | ) | (0.24 | ) | 0.05 | 0.12 | |||||||
Diluted net income (loss) per ordinary share2 |
(0.20 | ) | (0.27 | ) | (0.24 | ) | 0.05 | 0.12 | |||||||
Number of ordinary shares used in computing per share amounts (in thousands): | |||||||||||||||
Basic | 431,989 | 432,112 | 432,454 | 432,675 | 433,230 | ||||||||||
Diluted2 |
431,989 | 432,112 | 432,454 | 434,975 | 436,953 | ||||||||||
ASML - Quarterly Summary Ratios and other data 1 | |||||||||||||||
Three months ended, | |||||||||||||||
Dec 31, | Mar 29, | Jun 28, | Sep 27, | Dec 31, | |||||||||||
2008 | 2009 | 2009 | 2009 | 2009 | |||||||||||
Gross profit as a % of net sales | 7.9 | 6.7 | 12.5 | 34.4 | 38.0 | ||||||||||
Income (loss) from operations as a % of net sales | (27.4 | ) | (80.0 | ) | (45.0 | ) | 6.9 | 11.7 | |||||||
Net income (loss) as a % of net sales | (17.8 | ) | (63.8 | ) | (37.6 | ) | 3.6 | 8.7 | |||||||
Shareholders' equity as a % of total assets | 50.5 | 48.0 | 47.7 | 47.8 | 47.6 | ||||||||||
Income taxes as a % of income before income taxes | (32.4 | ) | (20.8 | ) | (16.6 | ) | (45.4 | ) | (22.2 | ) | |||||
Sales of systems (in units) | 25 | 11 | 10 | 24 | 25 | ||||||||||
ASP of system sales (EUR million) | 15.2 | 9.2 | 18.3 | 19.1 | 17.3 | ||||||||||
Value of systems backlog (EUR million) | 755 | 853 | 1,064 | 1,353 | 1,853 | ||||||||||
Systems backlog (in units) | 41 | 38 | 43 | 54 | 69 | ||||||||||
ASP of systems backlog (EUR million) | 18.4 | 22.4 | 24.7 | 25.1 | 26.8 | ||||||||||
Value of booked systems (EUR million) | 127 | 207 | 394 | 777 | 956 | ||||||||||
Net bookings (in units) | 13 | 8 | 15 | 35 | 40 | ||||||||||
ASP of booked systems (EUR million) | 9.8 | 25.8 | 26.3 | 22.2 | 23.9 | ||||||||||
Number of payroll employees in FTEs | 6,930 | 6,715 | 6,597 | 6,529 | 6,548 | ||||||||||
Number of temporary employees in FTEs | 1,329 | 959 | 868 | 917 | 1,137 | ||||||||||
ASML - Summary U.S. GAAP Consolidated Balance Sheets 1 | |||||||||||||||
Dec 31, | Mar 29, | Jun 28, | Sep 27, | Dec 31, | |||||||||||
2008 | 2009 | 2009 | 2009 | 2009 | |||||||||||
(in millions EUR) | |||||||||||||||
ASSETS | |||||||||||||||
Cash and cash equivalents | 1,109.2 | 1,151.0 | 1,092.7 | 1,018.0 | 1,037.1 | ||||||||||
Accounts receivable, net | 463.3 | 291.6 | 213.5 | 382.1 | 377.4 | ||||||||||
Finance receivables, net | 6.2 | 6.2 | 0.1 | 21.1 | 21.6 | ||||||||||
Current tax assets | 87.6 | - | - | - | 11.3 | ||||||||||
Inventories, net | 999.1 | 936.8 | 926.1 | 882.4 | 963.4 | ||||||||||
Deferred tax assets | 71.8 | 74.9 | 70.5 | 69.0 | 119.4 | ||||||||||
Other assets | 236.1 | 240.6 | 220.2 | 224.2 | 218.7 | ||||||||||
Total current assets | 2,973.3 | 2,701.1 | 2,523.1 | 2,596.8 | 2,748.9 | ||||||||||
Finance receivables, net | 31.0 | 29.2 | 20.6 | - | - | ||||||||||
Deferred tax assets | 148.1 | 173.2 | 198.9 | 193.5 | 133.3 | ||||||||||
Other assets | 88.2 | 89.5 | 53.8 | 68.1 | 77.0 | ||||||||||
Goodwill | 131.5 | 139.7 | 134.5 | 128.6 | 131.5 | ||||||||||
Other intangible assets, net | 26.7 | 25.6 | 22.3 | 19.0 | 18.1 | ||||||||||
Property, plant and equipment, net | 540.6 | 586.6 | 591.9 | 561.7 | 618.7 | ||||||||||
Total non-current assets | 966.1 | 1,043.8 | 1,022.0 | 970.9 | 978.6 | ||||||||||
Total assets | 3,939.4 | 3,744.9 | 3,545.1 | 3,567.7 | 3,727.5 | ||||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||||
Current liabilities | 1,008.3 | 1,017.5 | 940.9 | 949.3 | 1,044.2 | ||||||||||
Accrued liabilities and other liabilities | 70.0 | 48.2 | 45.6 | 44.7 | 44.3 | ||||||||||
Deferred and other tax liabilities | 209.7 | 204.9 | 200.6 | 193.7 | 188.4 | ||||||||||
Provisions | 15.5 | 16.9 | 14.8 | 13.5 | 12.7 | ||||||||||
Long-term debt | 647.1 | 661.4 | 651.9 | 660.2 | 663.1 | ||||||||||
Total non-current liabilities | 942.3 | 931.4 | 912.9 | 912.1 | 908.5 | ||||||||||
Total liabilities | 1,950.6 | 1,948.9 | 1,853.8 | 1,861.4 | 1,952.7 | ||||||||||
Shareholders’ equity | 1,988.8 | 1,796.0 |
1,691.3 |
1,706.3 | 1,774.8 | ||||||||||
Total liabilities and shareholders’ equity | 3,939.4 | 3,744.9 | 3,545.1 | 3,567.7 | 3,727.5 | ||||||||||
ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1 | ||||||||||||||||
Three months ended, | ||||||||||||||||
Dec 31, | Mar 29, | Jun 28, | Sep 27, | Dec 31, | ||||||||||||
2008 | 2009 | 2009 | 2009 | 2009 | ||||||||||||
(in millions EUR) | ||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||||
Net income (loss) | (88.0 | ) | (117.2 | ) | (104.0 | ) | 19.7 | 50.5 | ||||||||
Depreciation and amortization | 35.1 | 38.4 | 34.7 | 33.5 | 33.6 | |||||||||||
Impairment | 22.9 | 2.6 | 4.4 | 8.6 | 0.3 | |||||||||||
Loss (gain) on disposals of property, plant and equipment | 0.4 | 2.6 | (0.4 | ) | 0.9 | 1.0 | ||||||||||
Share-based payments | 3.2 | 3.5 | 2.6 | 2.8 | 4.5 | |||||||||||
Allowance for doubtful debts | 0.5 | - | 1.2 | 0.7 | 0.1 | |||||||||||
Allowance for obsolete inventory | 85.8 | 22.1 | 43.9 | 13.2 | 7.4 | |||||||||||
Deferred income taxes | (2.7 | ) | (27.0 | ) | (31.2 | ) | (4.5 | ) | 13.3 | |||||||
Change in assets and liabilities | (194.6 | ) | 157.2 | 110.7 | (140.3 | ) | (91.7 | ) | ||||||||
Net cash provided by (used in) operating activities | (137.4 | ) | 82.2 | 61.9 | (65.4 | ) | 19.0 | |||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||||||||
Purchases of property, plant and equipment | (71.1 | ) | (43.9 | ) | (39.9 | ) | (13.5 | ) | (7.7 | ) | ||||||
Proceeds from sale of property, plant and equipment | - | 1.2 | 5.7 | - | - | |||||||||||
Net cash used in investing activities | (71.1 | ) | (42.7 | ) | (34.2 | ) | (13.5 | ) | (7.7 | ) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||||
Dividend paid | - | - | (86.5 | ) | - | - | ||||||||||
Net proceeds from issuance of shares and stock options | 6.5 | 0.1 | 0.4 | 4.2 | 6.4 | |||||||||||
Excess tax benefits (deficiencies) from stock options | (1.9 | ) | (0.2 | ) | 0.5 | 0.7 | 1.0 | |||||||||
Net proceeds from other long-term debt | - | - | 0.1 | - | - | |||||||||||
Redemption and/or repayment of debt | (1.1 | ) | - | - | - | - | ||||||||||
Net cash provided by (used in) financing activities | 3.5 | (0.1 | ) | (85.5 | ) | 4.9 | 7.4 | |||||||||
Net cash flows | (205.0 | ) | 39.4 | (57.8 | ) | (74.0 | ) | 18.7 | ||||||||
Effect of changes in exchange rates on cash | 1.2 | 2.4 | (0.5 | ) | (0.7 | ) | 0.4 | |||||||||
Net increase (decrease) in cash & cash equivalents | (203.8 | ) | 41.8 | (58.3 | ) | (74.7 | ) | 19.1 | ||||||||
ASML - Notes to the Summary U.S. GAAP Consolidated Financial Statements
Basis of Presentation
ASML follows accounting principles generally accepted in the United States of America ("U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).
Principles of consolidation
The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.
Use of estimates
The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.
Recognition of revenues
ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a "Factory Acceptance Test" in ASML's cleanroom facilities, effectively replicating the operating conditions that will be present on the customer's site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer, if any. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but substantive rather than inconsequential or perfunctory a portion of the sales price is deferred. Although each system's performance is re-tested upon installation at the customer's site, ASML has never failed to successfully complete installation of a system at a customer’s premises.
For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.
Foreign currency risk management
The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.
It is the Company’s policy to hedge material transaction exposures, such as sales transactions and forecasted purchase transactions. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.
It is the Company’s policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.
As of December 31, 2009 EUR 41.8 million loss is classified as other comprehensive income, net of taxes, representing the total anticipated loss to be charged to net sales, and EUR 0.5 million gain representing the total anticipated gain to be released to cost of sales when the forecasted revenue and purchase transactions occur.
ASML – Reconciliation U.S. GAAP – IFRS 1 |
||||||||||
Net income | Three months ended, | Twelve months ended, | ||||||||
Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2009 | |||||||
(in thousands EUR) | ||||||||||
Net income (loss) under U.S. GAAP | (88,024) | 50,480 | 322,370 | (150,925) | ||||||
Share-based payments (see Note 1) | 481 | 89 | (2,529) | 2,401 | ||||||
Development costs (see Note 2) | 7,219 | (8,024) | 62,416 | 49,755 | ||||||
Reversal of write-downs (see Note 3) | - | (11,405) | - | 17,104 | ||||||
Income taxes (see Note 4) | (2,279) | 3,630 | (5,359) | 222 | ||||||
Net income (loss) under IFRS | (82,603) | 34,770 | 376,898 | (81,443) | ||||||
Shareholders’ equity | Dec 31, | Mar 29, | Jun 28, | Sep 27, | Dec 31, | |||||
2008 | 2009 | 2009 | 2009 | 2009 | ||||||
(in thousands EUR) | ||||||||||
Shareholders’ equity under U.S. GAAP | 1,988,769 | 1,795,951 | 1,691,240 | 1,706,271 | 1,774,768 | |||||
Share-based payments (see Note 1) | (6,537) | (7,088) | (4,918) | (460) | 2,397 | |||||
Development costs (see Note 2) | 201,717 | 215,452 | 235,945 | 259,665 | 251,556 | |||||
Reversal of write-downs (see Note 3) | - | - | - | 28,509 | 17,104 | |||||
Income taxes (see Note 4) | 4,794 | 3,361 | 2,797 | 1,370 | 4,982 | |||||
Shareholders’ equity under IFRS | 2,188,743 | 2,007,676 | 1,925,064 | 1,995,355 | 2,050,807 | |||||
Notes to the reconciliation from U.S. GAAP to IFRS |
||||||||||
Note 1 Share-based Payments
Under IFRS, ASML applies IFRS 2, "Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRS, at period end a deferred tax asset is computed on the basis of the tax deduction for the share-based payments under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.
As of January 1, 2006, ASML applies ASC 718 "Compensation- Stock Compensation” which requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. ASC 718’s general principle is that a deferred tax asset is established as the Company recognizes compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements. Therefore, changes in the Company’s share price do not affect the deferred tax asset recorded in the Company’s financial statements.
Note 2 Development costs
Under IFRS, ASML applies IAS 38, "Intangible Assets”. In accordance with IAS 38, ASML capitalizes certain development expenditures which are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.
Under U.S. GAAP, ASML applies ASC 730, "Research and Development”. In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.
Note 3 Reversal of write-downs
Under IFRS, ASML applies IAS 2 (revised), "Inventories”. In accordance with IAS 2, reversal of a prior period write-down as a result of a subsequent increase in value of inventory should be recognized in the period in which the value increase occurs.
Under U.S. GAAP, ASML applies ASC 330 Inventory. In accordance with ASC 330 reversal of a write-down is prohibited as a write-down creates a new cost basis.
Note 4 Income taxes
Under IFRS, ASML applies IAS 12, "Income Taxes” beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.
Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s rather than the purchaser’s tax jurisdiction.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers’ products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.
1 All quarterly and full year 2009 information in this press release is unaudited.
2 The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans for periods in which exercises would have a dilutive effect, the calculation of diluted net income per ordinary share does not assume exercise of such options when such exercises would be antidilutive.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ASML NVmehr Nachrichten
Analysen zu ASML NVmehr Analysen
17.01.25 | ASML NV Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
16.01.25 | ASML NV Buy | Goldman Sachs Group Inc. | |
14.01.25 | ASML NV Neutral | UBS AG | |
09.01.25 | ASML NV Buy | Jefferies & Company Inc. | |
07.01.25 | ASML NV Outperform | Bernstein Research |
Aktien in diesem Artikel
ASML NV | 733,60 | 0,12% |